MITCHELL BENSON, MD
Urology at Fort Washington Ave, New York, NY
License number
New York 136924
Category
Radiology
Type
Urology
Address
Address
161 Fort Washington Ave FLOOR 11TH, New York, NY 10032
Phone
(212) 305-0114
(212) 305-0129 (Fax)
(212) 305-0129 (Fax)
Personal information
See more information about MITCHELL BENSON at radaris.comName
Address
Phone
56 Court St APT 6B, Brooklyn, NY 11201
45 E End Ave APT 17A, New York, NY 10028
56 Court St #6B, Brooklyn, NY 11201
245 E 40Th St #29E, New York, NY 10016
1 Prospect St, Brooklyn, NY 11215
Organization information
See more information about MITCHELL BENSON at bizstanding.comMitchell Benson MD
161 Ft Washington Ave, New York, NY 10032
Industry:
Urologist
Phone:
(212) 305-0114 (Phone)
Mitchell Clark Benson
Professional information
Dr. Mitchell C Benson, New York NY - MD (Doctor of Medicine)
Specialties:
Urology
Address:
New York Center-Human Sexuality
161 Fort Washington Ave SUITE 1123, New York 10032
(212) 305-0123 (Phone)
Columbia Univ Med Ctr URO
161 Fort Washington Ave, New York 10032
(212) 305-0112 (Phone)
Columbia University Medical Center CAR
161 Fort Washington Ave, New York 10032
(212) 305-7060 (Phone)
Mantu Gupta, MD
161 Fort Washington Ave, New York 10032
(212) 305-6784 (Phone), (212) 342-6870 (Fax)
New York Center-Human Sexuality
161 Fort Washington Ave SUITE 1123, New York 10032
(212) 305-0123 (Phone)
161 Fort Washington Ave SUITE 1123, New York 10032
(212) 305-0123 (Phone)
Columbia Univ Med Ctr URO
161 Fort Washington Ave, New York 10032
(212) 305-0112 (Phone)
Columbia University Medical Center CAR
161 Fort Washington Ave, New York 10032
(212) 305-7060 (Phone)
Mantu Gupta, MD
161 Fort Washington Ave, New York 10032
(212) 305-6784 (Phone), (212) 342-6870 (Fax)
New York Center-Human Sexuality
161 Fort Washington Ave SUITE 1123, New York 10032
(212) 305-0123 (Phone)
Certifications:
Urology, 1984
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Education:
Medical School
Columbia University College Of Physicians and Surgeons
Graduated: 1977
Colum Presby
Graduated: 1982
Mt Sinai Hospital
Graduated: 1979
Johns Hopkins Hospital
Graduated: 1984
Columbia University College Of Physicians and Surgeons
Graduated: 1977
Colum Presby
Graduated: 1982
Mt Sinai Hospital
Graduated: 1979
Johns Hopkins Hospital
Graduated: 1984
Mitchell C Benson, New York NY
Specialties:
Urology, Medical Oncology, Public Health & General Preventive Medicine
Work:
Herbert Irving Pavilion
161 Fort Washington Ave, New York, NY 10032
161 Fort Washington Ave, New York, NY 10032
Education:
Columbia University (1977)
Mitchell Benson, New York NY
Specialties:
Urologist
Address:
622 W 168Th St, New York, NY 10032
1 Prospect Park Sw, Brooklyn, NY 11215
161 Fort Washington Ave, New York, NY 10032
1 Prospect Park Sw, Brooklyn, NY 11215
161 Fort Washington Ave, New York, NY 10032
Methods To Treat Or Prevent Hormone-Resistant Prostate Cancer Using Sirna Specific For Protocadherin-Pc, Or Other Inhibitors Of Protocadherin-Pc Expression Or Activity
US Patent:
2009031, Dec 17, 2009
Filed:
Aug 17, 2009
Appl. No.:
12/542231
Inventors:
Ralph BUTTYAN - New York NY, US
Mitchell C. BENSON - New York NY, US
Min-Wei CHEN - Flushing NY, US
Francis VACHEROT - Creteil, FR
Luis Carlos SOARES QUEIRES - Salvador, BR
Stephane TERRY - Creteil, FR
Alexandre DE LA TAILLE - Paris, FR
Sixtina GIL DIEZ DE MEDINA - Paris, FR
Mitchell C. BENSON - New York NY, US
Min-Wei CHEN - Flushing NY, US
Francis VACHEROT - Creteil, FR
Luis Carlos SOARES QUEIRES - Salvador, BR
Stephane TERRY - Creteil, FR
Alexandre DE LA TAILLE - Paris, FR
Sixtina GIL DIEZ DE MEDINA - Paris, FR
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The invention is directed to compounds and methods for treating or preventing hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity, including antisense oligonucleotides and antibodies. The invention also provides for the use of protocadherin-PC as an in vivo prostate cancer biomarker, and includes a kit for detecting prostate cancer in biological samples. Also covered by the invention is a transgenic non-human mammal engineered to overexpress protocadherin-PC specifically in the prostate.
Methods To Treat Or Prevent Hormone-Resistant Prostate Cancer Using Sirna Specific For Protocadherin-Pc, Or Other Inhibitors Of Protocadherin-Pc Expression Or Activity
US Patent:
2007024, Oct 25, 2007
Filed:
Feb 7, 2006
Appl. No.:
11/349473
Inventors:
Ralph Buttyan - New York NY, US
Mitchell Benson - New York NY, US
Min-Wei Chen - Flushing NY, US
Francis Vacherot - Creteil, FR
Luis Carlos Soares Queires - Salvador, BR
Stephane Terry - Creteil, FR
Alexandre De La Taille - Paris, FR
Sixtina Gil Diez De Medina - Paris, FR
Mitchell Benson - New York NY, US
Min-Wei Chen - Flushing NY, US
Francis Vacherot - Creteil, FR
Luis Carlos Soares Queires - Salvador, BR
Stephane Terry - Creteil, FR
Alexandre De La Taille - Paris, FR
Sixtina Gil Diez De Medina - Paris, FR
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
INSERM - Paris
INSERM - Paris
International Classification:
A61K 51/00, A01K 67/00, A61K 31/7052, C07H 21/00, C12N 1/00, C12Q 1/68, G01N 33/53, C12N 5/00, C07K 16/00, A61K 38/00, A61K 39/395
US Classification:
424001490, 424001110, 424001690, 424001730, 424130100, 424009100, 435243000, 435325000, 435410000, 435006000, 435007100, 514001000, 514002000, 514044000, 530387900, 530388100, 536023100, 800013000, 800014000, 800015000, 800017000, 800018000, 800003000
Abstract:
The invention is directed to compounds and methods for treating or preventing hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity, including antisense oligonucleotides and antibodies. The invention also provides for the use of protocadherin-PC as an in vivo prostate cancer biomarker, and includes a kit for detecting prostate cancer in biological samples. Also covered by the invention is a transgenic non-human mammal engineered to overexpress protocadherin-PC specifically in the prostate.
Rapidly Deployable Flexible Robotic Instrumentation
US Patent:
2013033, Dec 19, 2013
Filed:
Jul 26, 2011
Appl. No.:
13/812441
Inventors:
Roger Goldman - New York NY, US
Nabil Simaan - Nashville TN, US
Mitchell C. Benson - New York NY, US
Lara S. MacLachlan - New York NY, US
Nabil Simaan - Nashville TN, US
Mitchell C. Benson - New York NY, US
Lara S. MacLachlan - New York NY, US
International Classification:
A61B 19/00, A61B 1/00
US Classification:
600102, 600104
Abstract:
A robotic system and method are provided. The robotic system includes a continuum robot, an actuation unit, and a flexible positioning shaft. The continuum robot is configured to perform minimally invasive diagnostic, surgical or therapeutic techniques, and includes at least one continuum segment including a plurality of backbones. The continuum segment carries at least one diagnostic, surgical or therapeutic instrument in a flexible instrumentation housing that has a plurality of instrumentation channels. The actuation unit is configured to actuate the continuum robot by providing linear actuation to each of the plurality of backbones, and includes force sensors for measuring actuation forces. The flexible positioning shaft is configured to direct a position and orientation of the continuum robot and to couple the actuation unit to the continuum robot.